3-Bromo-5-nitropyridine

HCID 2762898CAS 15862-30-3

Grundinformationen

Standard-SMILES
O=[N+]([O-])c1cncc(Br)c1
InChIKey
WHYJVHQKKJHXTB-UHFFFAOYSA-N
Summenformel
C5H3BrN2O2
Durchschnittliche Molmasse
202,99 g/mol
Monoisotopische Masse
201,93779

Namen und Bezeichner

Bevorzugter Name
3-Bromo-5-nitropyridine
IUPAC
3-bromo-5-nitropyridine
Englischer Name
3-Bromo-5-nitropyridine
Summenformel
C5H3BrN2O2
Molmasse
202.99

Namen und Synonyme

3-Bromo-5-nitropyridine15862-30-3DTXSID80376553RefChem:93213DTXCID40327581677-831-63-bromo-5-nitro-pyridinePYRIDINE, 3-BROMO-5-NITRO-MFCD04114216SCHEMBL5297463-Bromo-5-nitropyridine, AldrichCPRCL0163
Weitere Namen anzeigen
3-nitro-5-bromopyridinePyridine,3-broMo-5-nitro-2-BROMO-5-NITROPYRIDINE ,98%3-BROMO-5-NITROPYRIDINE ISO 9001:2015 REACH
AKOS015833832CS-W003163AB17991GS-6476AC-22569SY005917AM20050843FT-0600155

Datenbank-Bezeichner

CAS
15862-30-3
PubChem CID
2762898
DTXSID
DTXSID80376553
EC Number
677-831-6

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,4
Polarare Oberfläche (TPSA)
58,7 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
0
Schwere Atome
10

Physikochemische Eigenschaften

Schmelzpunkt
111 · 111-115℃
Siedepunkt
251.6 · 251.6±20.0 °C(Predicted)
Dichte
1.833 · 1.833±0.06 g/cm3(Predicted)
storage temp.
Inert atmosphere,Room Temperature
pka
-1.16 · -1.16±0.20(Predicted)
Aggregatzustand
solid

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H301 (88.9%): Toxic if swallowed [Danger Acute toxicity, oral];H302 (11.1%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (11.1%): Harmful in contact with skin [Warning Acute toxicity, dermal];H315 (11.1%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (88.9%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (11.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (11.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 3 (88.9%);Acute Tox. 4 (11.1%);Acute Tox. 4 (11.1%);Skin Irrit. 2 (11.1%);Eye Dam. 1 (88.9%);Eye Irrit. 2A (11.1%);STOT SE 3 (11.1%)

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1 / PGIII
hs_code
2933399990
risk_code
25-41
hazard_code
T,Xi
safety_code
26-39-45

Chemie und Industrie

Vor- und nachgelagerte Produkte

Anbieter50 Anbieter

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
苏州启航生物科技有限公司18151111370 · [email protected]
温州共赢化学有限公司+86-0086-577-64498589 +86-15355981851 · [email protected]

Zugehörige Reaktionen

4

Verknüpfte Notizen

Wird geladen…